Indore-based startup Perkant Tech, inventor of an artificial intelligence (AI)-enabled med-tech multi-disease prognostic health platform, has raised Rs 6.6 crore in a seed funding round led by YourNest Venture Capital.
This round includes contributions of Rs 5 crore from YourNest, Rs 1 crore from the Government of India’s Atal New India Challenge (AIM, Niti Aayog), Rs 35 lakh from Villgro Foundation, and Rs 25 lakh from the accelerator Sanchi Connect who partnered with YourNest in its Velocity fast-track funding programme.
Perkant Tech was founded during COVID-19 in 2020 by Lokant Jain and Saniya Jeswani, two young engineers in their final year of college. It offers a medical device with an exclusive suite of AI-augmented health solutions which empowers individuals and healthcare providers with real-time, predictive health insights, ranging from preventative screenings to comprehensive monitoring. This sustainable, upgradable platform redefines healthcare with precision, adaptability and scalability, bridging critical gaps in accessibility and supporting a future of equitable healthcare for all.
This investment will enable Perkant Tech to enhance its AI-powered prognostic technology, accelerate the R&D efforts and support market expansion, customer acquisition strategies as the company gears up for its commercial launch following successful pilots with world-class partners. Additionally, the funds will also be allocated towards technology upgrades and software development to ensure seamless integration, real-time updates, and personalized health insights, preparing the company’s solutions for widespread adoption.
Perkant Tech holds a granted Indian patent and a pending US patent for an advanced apparatus designed to measure and acquire distress data from the human body, encompassing both psychological and physiological indicators.
